A Nomogram for the Prediction of Overall Survival in Patients With Stage II and III Non‑small Cell Lung Cancer Using a Population‑based Study

Oncology Letters - Greece
doi 10.3892/ol.2019.10977
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Better Overall Survival With Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Optimal Managements of Stage IIIA (N2) Non-Small Cell Lung Cancer Patients: A Population-Based Survival Analysis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

A Nomogram to Predict the Survival of Stage IIIA-N2 Non-Small Cell Lung Cancer After Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Surgical Quality of Wedge Resection Impacts Overall Survival in Patients With Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients With a Pathological Tumor Size Less Than 30 Mm

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

P1.16-39 a Nomogram for Predicting Survival of TNM8 Stage I Non-Small Cell Lung Cancer Patients to Tailor Potential Chemotherapy Candidates

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

Cancer Informatics
Cancer ResearchOncology
2019English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy